BIO of Ferid Murad

X close

Prof. Ferid Murad, is a Biochemist best known for his 1977 pioneering discovery work on nitric oxide and its role in increasing the diameter of the cardiovascular and other blood vessels for which he was awarded Nobel Prize in Medicine in 1998 along with Robert F. Furchgott and Louis J. Ignarro. The Nobel Committee evaluated that the identification of a biological role for nitric oxide was surprising for several reasons. Nitric oxide was known before the discovery mainly as a harmful air pollutant, released into the atmosphere from automobile engines and other combustion sources. In addition, it was a simple molecule, very different from the complex neurotransmitters and other signaling molecules that regulate many biological events. No other gas is known to act as a signaling molecule in the body. In addition to its use in cardiovascular drugs the work of Prof. Murad on nitric oxide led to the development of Viagra. Nitric oxide is the only gas known to act as a signaling molecule in the body, and regulates activities of the brain, intestines, kidneys, liver, lungs, stomach, and genitals.
Prof. Ferid Murad, attended DePauw University (1958), Western Reserve University (1965), and performed his internship and residency in medicine at Massachusetts General Hospital as and MD/PhD physician scientist. He worked as a clinical associate in the Heart Institute from 1967-70 at the National Institutes of Health. From 1970-1981, Prof. Murad was on the faculty at the University of Virginia, where he developed a new Clinical Pharmacology Division in the Department of Medicine as an Associate Professor in Medicine and Pharmacology. In 1981, he was appointed as Chief of Medicine of the Palo Alto Veterans Hospital, a Stanford-affiliated hospital. He also served as a Professor of Medicine and Pharmacology and the Associate Chairman of Medicine. Prof. Murad was acting Chairman of Medicine at Stanford University from 1986-1988. In 1988, Dr. Murad joined industry as Vice President at Abbott Laboratories, supervising approximately 1,500 scientists and staff. In 1993, he founded and served as President and CEO of Molecular Geriatrics Corporation. In April 1997, he joined the University of Texas-Houston as their first chairman of a newly-combined basic science department, Integrative Biology, Pharmacology and Physiology. There he also created a new Division of Clinical Pharmacology with his department and the Department of Medicine. In October 1998, Prof. Murad, along with his colleagues Robert F. Furchgott and Louis J. Ignarro, were awarded The Nobel Prize in Physiology or Medicine. The award was given to them for their discoveries concerning nitric oxide as a signaling molecule in the cardiovascular system specific to blood vessel dilation. After accepting the award, Dr. Murad began working in the dual role of Chairman of the Department of Integrative Biology, Pharmacology and Physiology and Director of the Institute of Molecular Medicine at the University of Texas-Houston. In 2011, Dr. Murad accepted an faculty appointment at The George Washington University, where he leads a lab program in the Department of Biochemistry and Molecular Biology. Prof. Murad has been recipient of many Awards including the Albert Lasker Basic Medical Research Award in 1996 for his discovery.
He is author of two books: Nitric Oxide: Biochemistry, Molecular Biology, and Therapeutic Implications (1995, with Louis J. Ignarro) and The Wellness Solution (2007, with Edward A Taub and David Oliphant).
As a Nobel Laureate, Dr. Murad has participated on panels with other Nobel Laureates to discuss methods to promote peace and education around the world.

www.flogen.org/

BIO of Toshikazu Yoshikawa

X close

Dr. Toshikazu Yoshikawa, 72, was educated at Kyoto Prefectural University of Medicine, Kyoto, Japan. Graduated in 1973, Licensed Medical Doctor (M.D.) at 1973, and Dr. Medicine (Ph.D.) in 1983. After acting as President of the Kyoto Prefectural University of Medicine, he is now President of Louis Pasteur Center for Medical Research, President of Japan Anti-Aging Foundation, Emeritus Professor, Kyoto Prefectural University of Medicine, Emeritus President of the Society for Free Radical Research (SFRR) Japan, and Emeritus President of Japanese Society of Anti-Aging Medicine.
Specialized in medicine, he has worked in various fields such as gastroenterology, free radical science, preventive medicine, food nutrition, disease biomarkers, genomics, proteomics, and lipidomics.
Having started free radical and reactive oxygen species (ROS) research at a young, he has been an internationally respected authority of free radical research. Free radicals and ROS are high reactive molecules known to involve in over 150 diseases. Since free radicals and ROS are keys to preventing and treatment of diseases, he has studied the relationship between free radicals and those various diseases including cancer, intestinal and other inflammatory diseases, diabetes, dementia, male fertility, and so on. By accumulating countless studies that reveal the close relationship of free radicals and ROS to health and longevity, his total publications are over 1200, and primary research publications are over 500, cumulating above 20000 citations. In collaboration with many prominent researchers around the world, the numbers are still growing today. He has also written numerous books for both masses and professionals about free radicals, preventive medicine, antiaging, and so on. As an editor, he has a carrier as editor-in-chief in “Pathophysiology”, an official Journal of the International Society for Pathophysiology, and “Journal of Clinical Biochemistry and Nutrition”, an official Journal of the Society for Free Radical Research Japan.
Dr. Yoshikawa’s contributions to the free radical study are not limited to publishing papers. He has founded many associations such as Society for Free Radical Research Japan, which is the Japanese branch of the worldwide Society for Free Radical Research International. He was first President of the SFRR International as Japanese, leading free radical research. His carrier on council members varies such as President of the Japanese Society of Lipid Peroxide and Free Radical Research, SFRR International, President of the Japanese Society of Lipid Peroxide and Free Radical Research, President of the Japanese Society of Functional Water, and President of Internationalization of Medical Services Association.
Today, as interest in the importance of free radicals is growing, his researches will receive more attention.

www.flogen.org/

BIO of Joao Ricardo Ribas

X close

Joao Ricardo Ribas Júnior, MD, 55, is born in the city of Ponta Grossa, in the Southern Part of Brazil, on Christmas, 1964.
At an early age, he developed a strong interest in people and, because of that, he was encouraged by the family to go to Medical School. And he enrolled at the Federal University of his home state, Parana, where he graduated.
Soon after graduation, he decided to take a sabbatical period from Medicine and went to Europe, where he met a French Nurse that had joined - and introduced him to Doctors without Borders. He then traveled to a Cambodian Refugee Camp in Thailand, where he had the first direct contact with the Non-Governmental Organization.
He then found a meaning for his desire of helping the needy. He went back to Brazil to get a specialty in Tropical Diseases, in order to join the international Nobel-Prize-Winner institution. He was first assigned to serve in Angola, Africa. At that time, there was a Civil War going on, and he faced the risks of the domestic conflict and that made him start thinking about what he could do to improve people´s quality of life.
Once again he went back to Brazil for a new objective: becoming a surgeon. He got his Trauma training in Rio de Janeiro, the only city in the world that is not at war where organized crime uses Heavy Caliber Military Rifles to control Drug Operations.
He fell in love with the Marvelous City. He decided to dedicate his professional life to helping the least privileged in his own country.
And he realized that as a surgeon he could only help a certain number of people, but in Public Office, he would exponentiate the positive effect on the population. And he went into public life to keep saving lives.
For more than ten years, he has served as City Councillor in the City of Rio de Janeiro and has also held Executive Offices as Secretary of State for Human Rights in the State of Rio de Janeiro and Assistant Secretary of Health in São João do Meriti, a major city in Greater Rio.
He has improved a great deal the life of millions of people with laws and programs focused on Public Health, Sustainability, Animal Protection, and LGBT issues.

www.flogen.org/

BIO of Davis Joseph

X close

Between 2013 and 2021, Davis Joseph has received 18 honors, awards, and distinctions from various Canadian institutions both for his academic performance and for his service to his community. These institutions include the ‘’Collège Notre-Dame’’, ‘’Collège Jean-de-Brébeuf’’ (where he received a scholarship of excellence and graduated with a diploma in health Sciences), the Montreal Geriatric institution (for his hospital service), the department of oncology of the Jewish General hospital (where he was selected as a student observer), the University of Montreal and the University of Waterloo.
Mr. Joseph has achieved success in every single field he has participated in. In fact, through his rigorous academic discipline, Mr. Joseph has distinguished himself in all the academic fields he has studied, receiving merits and distinctions in French, English (twice), Mathematics (twice), natural and Social Sciences (twice) as well as a merit for his academic results in all fields. He was also acknowledged for his regular contributions to his music department as well as his contribution to Expo-Sciences Hydro-Québec. He was elected class representative in his first year of University and was a member of the executive council of his student association at the faculty of medicine in the university of Montreal. Davis Joseph is currently completing his university studies in Montreal, Canada with an excellent GPA average of above 4.0.
Mr Joseph has regularly been a volunteer at various events. He is dedicated to serving his community and helping whenever it Is possible. His positive attitude and determination make him an excellent representative of the student body in whatever event he signs up for.
Mr. Joseph enjoys playing piano Jazz, the bassoon, swimming and playing basketball.

www.flogen.org/

BIO of Nguyen Tran

X close

Pr. Nguyen TRAN, 54, manages his pedagogical and research investment in the School of Surgery of Nancy, Faculty of Medicine, University of Lorraine. This facility is now one of the biggest training centers in Europe dedicated to technological innovation in surgery and in advanced multidisciplinary therapeutic validation.
In research, he focusses his interest in the area of innovative strategies to repair chronic heart failure. He has contributed to the development of cardiac cell transplantation and cardiac tissue engineering to replace dysfunctional, necrotic, and/or apoptotic cardiomyocytes with (i) new cells of mesodermal origin and (ii) new 3-dimensional polymeric scaffolds. In 2006, his team was the first in France to perform a clinical comparative investigation to evaluate the contribution of direct injection of mesenchymal stem cells in infarct areas. Recently, he leads a project in the development an original Direct Cardiac Compression cardiac assist device dedicated to the assistance of patients suffering from end-stage chronic heart failure. This type of assistance allows treatment of heart failure without direct contact with the patient's blood (unlike circulatory assistance where blood contact is a problem) and without requiring major surgery.
In Pedagogy, he develops and impulses the simulation approaches to certify the surgical skills of young doctors. He is one of the founding members of the SoFraSims (French Health Simulation Society) sponsored by the French High Authority of Health (HAS). From 2019, he has joined the French National Digital Council as a representative of researchers.

www.flogen.org/

BIO of Shigeru Hirano

X close

Dr. Shigeru Hirano received his M.D. at Kyoto University in 1990 and began his residency at Kyoto University Hospital. Following his residency, he became a clinical staff at Tenri Hospital until 1994 and attended the Graduate School of Medicine at Kyoto University once again to receive his Ph.D. with a focus on Otolaryngology-Head and neck surgery.
In 1998, he began his career as an assistant professor at Kyoto University while also contributing to research as a research fellow at the University of California and the University of Wisconsin. After his successive role as an assistant professor, in 2005, he received the title of Associate Professor at Kyoto University.
In 2015, due to his hard work as an associate professor, he became the chair of the Department of Otolaryngology-Head Neck Surgery at Kyoto Prefectural University of Medicine.

www.flogen.org/

BIO of Scott Waldman

X close

Scott A. Waldman, MD, PhD, FCP, FAHA, FNAI
Dr. Scott Waldman obtained his PhD degree from Thomas Jefferson University, and his MD degree from Stanford University. He was a postdoctoral fellow at the University of Virginia and Stanford University in the Division of Clinical Pharmacology in the laboratory of Ferid Murad, MD, PhD, who won the 1998 Noble Prize in Physiology or Medicine. He is the Samuel MV Hamilton Professor of Medicine, Director of the Gastrointestinal Cancer Program of the Kimmel Cancer Center, and Chairman of the Department of Pharmacology and Experimental Therapeutics of Thomas Jefferson University. He directs the MD-PhD Program and the NIH-sponsored Postdoctoral Training Program in Clinical Pharmacology at Jefferson. He is a past member of the American Board of Clinical Pharmacology, a past Regent of the American College of Clinical Pharmacology (ACCP), a past-President of the American Society for Clinical Pharmacology and Therapeutics, and Chair of the Scientific Program Committee and Council Member of the American Society for Pharmacology and Experimental Therapeutics. He is a Fellow of the American College of Clinical Pharmacology (FCP), the American Heart Association (FAHA), and the National Academy of Inventors (FNAI). Dr. Waldman’s research interests focus on clinical pharmacology and translational medicine in the context of gastrointestinal malignancies and obesity.

www.flogen.org/